White House to announce drug pricing deal with Regeneron, source says
23/04/2026 16:45
WASHINGTON, April 23 (Reuters) - The White House will announce a drug pricing deal with pharmaceutical company Regeneron REGN.O on Thursday, according to a source familiar with the matter. (Reporting by Trevor Hunnicutt; Writing by Ryan Patrick Jones; Editing by Susan Heavey) ((ryan.jones@thomsonreuters.com; +1 437 242 1761))
Recent news on Regeneron Pharmaceuticals
See all newsEyePoint to halve workforce after experimental drug fails second late-stage trial (updated)
EyePoint to cut workforce by half after experimental drug fails second late-stage trial
Brief: Sanofi, pCPA Sign Letter Of Intent For Dupixent® Across Four Indications In Dermatology, Respiratory Care
Brief: Regeneron Pharmaceuticals Says Pasatru Shows Sustained Efficacy & Consistent Safety Profile From Weeks 56 To 84
Brief: Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment To License And Collaboration Agreement